- ►bmj.com [PDF] WY Zhang, A Po, HS Dua, A Azuara-Blanco - British Medical Journal, 2001 - bjo.bmj.com Abstract Aim—To evaluate the comparative eY- cacy and tolerance of latanoprost
versus timolol through a meta-analysis of ran- domised controlled trials (RCTs).
Methods—Systematic retrieval of RCTs of latanoprost versus timolol to ... Cited by 36 - Related articles - BL Direct - All 9 versions
TR Einarson, NA Kulin, D Tingey, M Iskedjian - Clinical therapeutics, 2000 - Elsevier Methods: This meta-analysis combined data from all randomized controlled trials
comparing the effects on IOP of latanoprost and brimonidine treatment in adults
with a baseline IOP ≥20 mm Hg. MEDLINE ® and EMBASE ® were searched for ... Cited by 15 - Related articles - BL Direct - All 6 versions
MK Niazi, N Raja - J Ayub Med Coll Abbottabad, 2004 - ayubmed.edu.pk Glaucoma, which causes optic nerve damage and visual field loss, is the most
important cause of irreversible blindness worldwide. 1 The mainstay of drug
treatment for glaucoma is timolol, a topical blocker. However, blockers are ... Cited by 2 - Related articles - Cached - All 5 versions
[CITATION] the Spanish Latanoprost Study Group. Efficacy and side effects of latanoprost monotherapy …
RL Stamper - Survey of Ophthalmology, 2002 - Elsevier Prior to 1978, only three classes of medications were available for the
treatment of chronic glaucoma (both open- and closed-angle). These were topical
miotics, topical nonselective sympathomimetics, and oral carbonic anhydrase ... Cited by 28 - Related articles - BL Direct - All 7 versions
R De Natale, E Draghi, MT Dorigo - Acta Ophthalmologica Scandinavica, 2004 - osservatorioarno.cineca.org ABSTRACT. Purpose: The aim of the present study was to investigate how the
medical treatment of glaucoma changed between 1997 and 2002, since the advent of
prostaglandin derivatives, with regard to drug prescriptions and ... Cited by 15 - Related articles - View as HTML - BL Direct - All 4 versions
C Costagliola, A Del Prete, M Verolino, P … - Graefe's Archive for Clinical and Experimental …, 2002 - Springer Abstract Purpose: To assess the efficacy and side effects of 0.005% latanoprost
once daily during 3 years of treatment in glaucomatous pa- tients in whom
intraocular pressure (IOP) was not adequately controlled by beta-blockers ... Cited by 15 - Related articles - BL Direct - All 4 versions
C Baudouin, JF Rouland, C Le Pen - European journal of ophthalmology, 2003 - ncbi.nlm.nih.gov PURPOSE: To analyze quantitative changes in glaucoma treatment strategies
between 1997 and 2000 in France. METHODS: Numbers of ab externo trabeculectomies
and other glaucoma surgeries were extracted from the national database of ... Cited by 29 - Related articles - BL Direct
MJ Walland - Clinical and Experimental Ophthalmology, 2004 - 万方数据资源系统 Abstract Aim: To document the change in pattern of glaucoma treatment in
Australia over the decade 1994-2003. Methods: Observational study: retrospective
data audit. Results: The total number of prescriptions for glaucoma items ... Cited by 32 - Related articles - BL Direct - All 2 versions
K Hedman, A Alm - European Journal of Ophthalmology, 2000 - jnephrol.com PURPOSE. To compare the intraocular pressure (IOP) reduction by latanoprost and
timolol, and to study factors of prognostic value for assessing this reduction.
METHODS. We analyzed 829 patients included in three phase III studies ... Cited by 58 - Related articles - View as HTML - BL Direct - All 9 versions
